Digital Health Frontier
By John Halamka and Paul Cerrato - The latest proposed rules from CMS and FDA emphasize the need for a balanced, nuanced approach to digital innovation.
By John Halamka and Paul Cerrato - Challenging the status quo in technology and medicine can take a heavy toll, but history has demonstrated that it often yields measurable benefits for both clinicians and patients.
By John Halamka and Paul Cerrato - Smartphone-based applications may help detect atrial fibrillation, warn clinicians about worsening mental status, and improve the management of heart failure.
By John Halamka and Paul Cerrato - Every clinician knows that early detection is one of the most powerful tools we have in the war on cancer. Several computational tools are enabling us to make early detection a reality, at least in two specialties.
By John Halamka and Paul Cerrato - Two recent studies strongly suggest that sepsis predictive algorithms may in fact be ready for “prime time.”
By John Halamka and Paul Cerrato - A recent report points out that providers are not taking the necessary steps to secure the mobile devices connected to their network.
By John Halamka and Paul Cerrato - A growing number of studies show that drug/gene interactions can influence how patients respond to specific medications. But there are barriers that prevent the full implementation of pharmacogenomic testing into routine clinical practice.
By John Halamka and Paul Cerrato - Concerns about algorithmic bias and poor performance of the models have made many stakeholders more cautious about using these digital tools in patient care. That’s about to change.
By John Halamka and Paul Cerrato - The daily headlines may suggest a dystopian future, but the evidence shows the world is actually becoming a healthier, safer place to live.
By John Halamka and Paul Cerrato - Cognitive errors challenge clinicians and technologists alike. Being aware of the types of mistakes that can occur is the first step toward fixing them.
By John Halamka and Paul Cerrato - The technology, which has been successful used in other industries, is slowly emerging as an innovative way to “clone” organ systems and genomic data to personalize patient care.
By John Halamka and Paul Cerrato - Measuring a long list of biomarkers with the help of wearables, lab testing, medical imaging, and genomic sequencing is the future of precision medicine. Creating these integrative personal omics profiles (iPOPs) has the potential to transform health care.